p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation-Reference-Cited by-全球学者库

p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation

Published:2015-07-28 Issue:7 Volume:10 Page:e0133467
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Siu Michelle K. Y.,Kong Daniel S. H.,Ngai Sheila Y. P.,Chan Hoi Yan,Jiang Lili,Wong Esther S. Y.,Liu Stephanie S.,Chan Karen K. L.,Ngan Hextan Y. S.,Cheung Annie N. Y.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths;R Siegel;CA: a cancer journal for clinicians,2011

2. Two pathogenetic types of endometrial carcinoma;JV Bokhman;Gynecologic oncology,1983

3. Endometrial Carcinoma;A Di Cristofano;Annu Rev Pathol,2007

4. p21-activated kinases in cancer;R Kumar;Nat Rev Cancer,2006

5. The emerging importance of group II PAKs;CM Wells;Biochem J,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological role of the PAK4 signaling pathway: A prospective therapeutic target for multivarious cancers;Arabian Journal of Chemistry;2023-01

2. The significance of PAK4 in signaling and clinicopathology: A review;Open Life Sciences;2022-01-01

3. Why is PAK4 overexpressed in cancer?;The International Journal of Biochemistry & Cell Biology;2021-09

4. Coordinated dysregulation of cancer progression by the HER family and p21-activated kinases;Cancer and Metastasis Reviews;2020-08-21

5. Knockdown of PAK1 Inhibits the Proliferation and Invasion of Non–Small Cell Lung Cancer Cells Through the ERK Pathway;Applied Immunohistochemistry & Molecular Morphology;2019-08-06